Bladder Cancer Detection Kit Market to Hit USD 2.99 Billion by 2032, Driven by Advancements in Non-Invasive Technologies | Research by SNS Insider [Yahoo! Finance]
Exact Sciences Corporation (EXAS)
Last exact sciences corporation earnings: 2/11 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.exactsciences.com/investor-relations/default.aspx
Company Research
Source: Yahoo! Finance
Austin, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Bladder Cancer Detection Kit Market Size & Growth Analysis: “According to SNS Insider, The Bladder Cancer Detection Kit Market Size was valued at USD 1.63 Billion in 2023 and is projected to reach USD 2.99 Billion by 2032, growing at a compound annual growth rate (CAGR) of 7.04% from 2024 to 2032.” Rising Demand and Technological Advancements Drive Bladder Cancer Detection Market The bladder cancer detection kit market is expanding as the rising prevalence of cancer globally underscores the critical need for early diagnostic tools. Early detection is essential as it improves survival rates, encouraging healthcare providers to adopt advanced technologies like biomarker-based kits and liquid biopsies. These innovative solutions are not only more accurate but also less invasive, aligning with patient preferences and driving widespread adoption. Additionally, the growing aging population and lifestyle factors such as smoking are increasing
Show less
Read more
Impact Snapshot
Event Time:
EXAS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EXAS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EXAS alerts
High impacting Exact Sciences Corporation news events
Weekly update
A roundup of the hottest topics
EXAS
News
- Exact Sciences to Participate in J.P. Morgan Healthcare ConferenceBusiness Wire
- Exact Sciences Co. (NASDAQ: EXAS) had its price target lowered by analysts at Bank of America Co. from $75.00 to $72.00. They now have a "buy" rating on the stock.MarketBeat
- AAPA Awarded Grant from Exact Sciences to Improve Colorectal Cancer Screening Rates [Yahoo! Finance]Yahoo! Finance
- Exploring High Growth Tech Stocks in December 2024 [Yahoo! Finance]Yahoo! Finance
- Exact Sciences and Lil Jon Partner on "Get Low #2" Campaign to Encourage Colon Cancer Screening [Yahoo! Finance]Yahoo! Finance
EXAS
Earnings
- 11/5/24 - Miss
EXAS
Sec Filings
- 1/6/25 - Form 4
- 1/6/25 - Form 3
- 1/6/25 - Form 8-K
- EXAS's page on the SEC website